{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:05:56Z","timestamp":1753887956699},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00392-015-0911-7","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T11:28:44Z","timestamp":1441106924000},"page":"230-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents"],"prefix":"10.1007","volume":"105","author":[{"given":"Miroslaw","family":"Ferenc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz Joachim","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Comberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firas","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Valina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurel","family":"Toma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Kuebler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Riede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"issue":"9","key":"911_CR1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"GD Dangas","year":"2013","unstructured":"Dangas GD, Serruys PW, Kereiakes DJ, Hermiller J, Rizvi A, Newman W, Sudhir K, Smith RS Jr, Cao S, Theodoropoulos K, Cutlip DE, Lansky AJ, Stone GW (2013) Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv 6(9):914\u2013922. doi: 10.1016\/j.jcin.2013.05.005","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"911_CR2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17):2126\u20132130. doi: 10.1001\/jama.293.17.2126","journal-title":"JAMA"},{"issue":"3","key":"911_CR3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ahj.2009.11.032","volume":"159","author":"M Ferenc","year":"2010","unstructured":"Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T, Zhao M, Buettner HJ, Neumann FJ (2010) Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents. Am Heart J 159(3):454\u2013461. doi: 10.1016\/j.ahj.2009.11.032","journal-title":"Am Heart J"},{"issue":"3","key":"911_CR4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ccd.20951","volume":"69","author":"C Mario Di","year":"2007","unstructured":"Di Mario C, Morici N, Godino C, Goktekin O, Tamburino C, Barbagallo R, Antoniucci D, Grube E, Airoldi F, Zoccai GB, Colombo A, Sangiorgi GM (2007) Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients. Catheter Cardiovasc Interv 69(3):416\u2013424. doi: 10.1002\/ccd.20951","journal-title":"Catheter Cardiovasc Interv"},{"key":"911_CR5","doi-asserted-by":"crossref","unstructured":"Pan M, Suarez de Lezo J, Medina A, Romero M, Delgado A, Segura J, Ojeda S, Mazuelos F, Hernandez E, Melian F, Pavlovic D, Esteban F, Herrador J (2007) Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. Am Heart J 153(1):15 e11\u201317. doi: 10.1016\/j.ahj.2006.10.017","DOI":"10.1016\/j.ahj.2006.10.017"},{"issue":"1","key":"911_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2013.04.015","volume":"62","author":"M Maeng","year":"2013","unstructured":"Maeng M, Holm NR, Erglis A, Kumsars I, Niemela M, Kervinen K, Jensen JS, Galloe A, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Nikus K, Vikman S, Ravkilde J, James S, Aaroe J, Ylitalo A, Helqvist S, Sjogren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Christiansen EH, Lassen JF, Thuesen L (2013) Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: nordic Bifurcation Study 5-year follow-up results. J Am Coll Cardiol 62(1):30\u201334. doi: 10.1016\/j.jacc.2013.04.015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"911_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","volume":"58","author":"GW Stone","year":"2011","unstructured":"Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, Kereiakes DJ (2011) Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol 58(1):19\u201325. doi: 10.1016\/j.jacc.2011.02.022","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"911_CR8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2013.12.036","volume":"63","author":"M Taniwaki","year":"2014","unstructured":"Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, Buszman PE, Kelbaek H, Windecker S (2014) 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). J Am Coll Cardiol 63(16):1617\u20131625. doi: 10.1016\/j.jacc.2013.12.036","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"911_CR9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00392-012-0414-8","volume":"101","author":"A Waha de","year":"2012","unstructured":"de Waha A, Cassese S, Park DW, Burzotta F, Byrne RA, Tada T, King LA, Park SJ, Schomig A, Kastrati A (2012) Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials. Clin Res Cardiol 101(6):461\u2013467. doi: 10.1007\/s00392-012-0414-8","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"911_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00392-013-0546-5","volume":"102","author":"I Akin","year":"2013","unstructured":"Akin I, Hochadel M, Abdel-Wahab M, Senges J, Richardt G, Schneider S, Tebbe U, Kuck KH, Nienaber CA (2013) Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 102(5):371\u2013381. doi: 10.1007\/s00392-013-0546-5","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"911_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00392-014-0662-x","volume":"103","author":"I Akin","year":"2014","unstructured":"Akin I, Nienaber CA, Richardt G, Tolg R, Hochadel M, Schneider S, Senges J, Tebbe U, Zeymer U, Sabin G, Kuck KH, Bergmann MW (2014) Risk factors for clinical events at 1-year follow-up after drug-eluting stent implantation: results from the prospective multicenter German DES.DE registry. Clin Res Cardiol 103(5):363\u2013372. doi: 10.1007\/s00392-014-0662-x","journal-title":"Clin Res Cardiol"},{"issue":"23","key":"911_CR12","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/eurheartj\/ehn455","volume":"29","author":"M Ferenc","year":"2008","unstructured":"Ferenc M, Gick M, Kienzle RP, Bestehorn HP, Werner KD, Comberg T, Kuebler P, Buttner HJ, Neumann FJ (2008) Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J 29(23):2859\u20132867. doi: 10.1093\/eurheartj\/ehn455","journal-title":"Eur Heart J"},{"issue":"2","key":"911_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ccd.21314","volume":"71","author":"Y Louvard","year":"2008","unstructured":"Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefevre T (2008) Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv 71(2):175\u2013183. doi: 10.1002\/ccd.21314","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"911_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cjca.2012.01.020","volume":"28","author":"X Freixa","year":"2012","unstructured":"Freixa X, Carpen M, Kotowycz MA, Ho KW, Krimly A, Osten MD, Overgaard CB, Horlick EM, Seidelin PH, Dzavik V (2012) Long-term outcomes after percutaneous intervention of the internal thoracic artery anastomosis: the use of drug-eluting stents is associated with a higher need of repeat revascularization. Can J Cardiol 28(4):458\u2013463. doi: 10.1016\/j.cjca.2012.01.020","journal-title":"Can J Cardiol"},{"issue":"1","key":"911_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4244\/EIJV9I1A7","volume":"9","author":"G Stankovic","year":"2013","unstructured":"Stankovic G, Lefevre T, Chieffo A, Hildick-Smith D, Lassen JF, Pan M, Darremont O, Albiero R, Ferenc M, Finet G, Adriaenssens T, Koo BK, Burzotta F, Louvard Y (2013) Consensus from the 7th European Bifurcation Club meeting. EuroIntervention 9(1):36\u201345. doi: 10.4244\/EIJV9I1A7","journal-title":"EuroIntervention"},{"issue":"18","key":"911_CR16","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jacc.2013.07.041","volume":"62","author":"JY Hahn","year":"2013","unstructured":"Hahn JY, Chun WJ, Kim JH, Song YB, Oh JH, Koo BK, Rha SW, Yu CW, Park JS, Jeong JO, Choi SH, Choi JH, Jeong MH, Yoon JH, Jang Y, Tahk SJ, Kim HS, Gwon HC (2013) Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II Registry (COronary BIfurcation Stenting). J Am Coll Cardiol 62(18):1654\u20131659. doi: 10.1016\/j.jacc.2013.07.041","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"911_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCULATIONAHA.110.966879","volume":"123","author":"M Niemela","year":"2011","unstructured":"Niemela M, Kervinen K, Erglis A, Holm NR, Maeng M, Christiansen EH, Kumsars I, Jegere S, Dombrovskis A, Gunnes P, Stavnes S, Steigen TK, Trovik T, Eskola M, Vikman S, Romppanen H, Makikallio T, Hansen KN, Thayssen P, Aberge L, Jensen LO, Hervold A, Airaksinen J, Pietila M, Frobert O, Kellerth T, Ravkilde J, Aaroe J, Jensen JS, Helqvist S, Sjogren I, James S, Miettinen H, Lassen JF, Thuesen L (2011) Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III. Circulation 123(1):79\u201386. doi: 10.1161\/CIRCULATIONAHA.110.966879","journal-title":"Circulation"},{"issue":"16","key":"911_CR18","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2010.02.008","volume":"55","author":"YB Song","year":"2010","unstructured":"Song YB, Hahn JY, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Seong IW, Yang JY, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ, Gwon HC (2010) Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry. J Am Coll Cardiol 55(16):1743\u20131750. doi: 10.1016\/j.jacc.2010.02.008","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"911_CR19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcin.2010.12.005","volume":"4","author":"F Burzotta","year":"2011","unstructured":"Burzotta F, Trani C, Todaro D, Mariani L, Talarico GP, Tommasino A, Giammarinaro M, Niccoli G, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F (2011) Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. JACC Cardiovasc Interv 4(3):327\u2013335. doi: 10.1016\/j.jcin.2010.12.005","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"911_CR20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.carrev.2013.01.002","volume":"14","author":"F Burzotta","year":"2013","unstructured":"Burzotta F, Trani C, Talarico GP, Tommasino A, Todaro D, Coluccia V, Pirozzolo G, Niccoli G, Leone AM, Porto I, Schiavoni G, Crea F (2013) Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents. Cardiovasc Revasc Med 14(3):122\u2013127. doi: 10.1016\/j.carrev.2013.01.002","journal-title":"Cardiovasc Revasc Med"},{"issue":"12","key":"911_CR21","first-page":"630","volume":"26","author":"M Ferenc","year":"2014","unstructured":"Ferenc M, Kornowski R, Belardi J, Serruys P, Silber S, Widimsky P, Windecker S, Neumann FJ (2014) Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions. J Invasive Cardiol 26(12):630\u2013638","journal-title":"J Invasive Cardiol"},{"issue":"6","key":"911_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.carrev.2013.09.006","volume":"14","author":"C Costopoulos","year":"2013","unstructured":"Costopoulos C, Latib A, Ferrarello S, Naganuma T, Sticchi A, Filippo F, Giannini F, Basavarajaiah S, Kawaguchi M, Naim C, Candreva A, Carlino M, Chieffo A, Montorfano M, Colombo A (2013) First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations. Cardiovasc Revasc Med 14(6):311\u2013315. doi: 10.1016\/j.carrev.2013.09.006","journal-title":"Cardiovasc Revasc Med"},{"issue":"14","key":"911_CR23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","volume":"50","author":"A Schomig","year":"2007","unstructured":"Schomig A, Dibra A, Windecker S, Mehilli J, Suarez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Juni P, Pfisterer ME, Meier B, Kastrati A (2007) A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50(14):1373\u20131380. doi: 10.1016\/j.jacc.2007.06.047","journal-title":"J Am Coll Cardiol"},{"key":"911_CR24","doi-asserted-by":"crossref","unstructured":"Park KW, Kang SH, Velders MA, Shin DH, Hahn S, Lim WH, Yang HM, Lee HY, Van Boven AJ, Hofma SH, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Kim HS (2013) Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials. Am Heart J 165(2):241\u2013250 e244. doi: 10.1016\/j.ahj.2012.08.007","DOI":"10.1016\/j.ahj.2012.08.007"},{"issue":"22","key":"911_CR25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/heartjnl-2012-302519","volume":"98","author":"S Cassese","year":"2012","unstructured":"Cassese S, Ndrepepa G, King LA, Tada T, Fusaro M, Kastrati A (2012) Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison. Heart 98(22):1632\u20131640. doi: 10.1136\/heartjnl-2012-302519","journal-title":"Heart"},{"issue":"9","key":"911_CR26","first-page":"436","volume":"25","author":"S Ferrarello","year":"2013","unstructured":"Ferrarello S, Costopoulos C, Latib A, Naganuma T, Sticchi A, Figini F, Basavarajaiah S, Carlino M, Chieffo A, Montorfano M, Kawaguchi M, Naim C, Giannini F, Colombo A (2013) The role of everolimus-eluting and resolute zotarolimus-eluting stents in the treatment of coronary bifurcations. J Invasive Cardiol 25(9):436\u2013440","journal-title":"J Invasive Cardiol"},{"issue":"9824","key":"911_CR27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","volume":"379","author":"T Palmerini","year":"2012","unstructured":"Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D\u2019Ascenzo F, Kimura T, Briguori C, Sabate M, Kim HS, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G, Marullo A, Kirtane AJ, Leon MB, Stone GW (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379(9824):1393\u20131402. doi: 10.1016\/S0140-6736(12)60324-9","journal-title":"Lancet"},{"issue":"6","key":"911_CR28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00392-014-0671-9","volume":"103","author":"A Schulz","year":"2014","unstructured":"Schulz A, Hauschild T, Kleber FX (2014) Treatment of coronary de novo bifurcation lesions with DCB only strategy. Clin Res Cardiol 103(6):451\u2013456. doi: 10.1007\/s00392-014-0671-9","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-015-0911-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-015-0911-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:31:14Z","timestamp":1559046674000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-015-0911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1007\/s00392-015-0911-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}